<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-10.anc" start="27181" end="27192" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="carichter" text="Protein isolated from cytoplasm was separated by SDS-PAGE on 10% polyacrylamide gels and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose membranes (NitroBind, MSI, Westborough, MA), then incubated with primary antibody overnight at 4¡C." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="7653" end="7661" sStart="null" offset="391" sid="r8.suggest.v.0357" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="Microglia in the central nervous system express scavenger receptors and are involved in the oxidized LDL uptake and metabolism [ 34 ] . These cells are, thus, the macrophage-equivalent in the central nervous system [ 35 ] . Results from this laboratory showed that cholesterol oxides can cause programmed cell death in microglia [ 7 ] , which suggests that microglia, similar to macrophages, can be a potential target for oxidized LDL toxicity." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="19871" end="19881" sStart="null" offset="58" sid="r10.particular.j.0797" wn="2" wnkey="particular%5:00:02:specific:00" annotator="veweser" text="Selective toxicity of cholesterol oxides toward a particular cell type was also observed in our previous studies [ 29 31 32 33 ] . Further experiments with Western blot analyses indicated that the cytotoxicity of cholesterol oxides was associated with their abilities to cause c-jun activation, as evidenced by the increase in activated c-jun, i.e., phospho-c-jun, in 25-OH-cholesterol treated cells but not in 7-?-OH-cholesterol treated cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="4834" end="4844" sStart="null" offset="53" sid="r10.particular.j.0952" wn="1" wnkey="particular%5:00:00:specific:00" annotator="brubin" text="Depending on the experimental system and the particular question asked, PPAR? can be involved with pro-atherogenesis or anti-atherogenesis." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="27581" end="27585" sStart="null" offset="240" sid="r8.life.n.0794" wn="10 11" wnkey="null" annotator="jeneale" text="Specific bands were detected by incubating the membrane with horseradish peroxidase conjugated secondary antibody for 45 minutes at room temperature, then with ECL Western Blotting Detection Reagents (Amersham Life Science, Arlington Heights, IL) according to the manufacturer's protocol." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="10985" end="10991" sStart="null" offset="4" sid="r9.level.n.0825" wn="1" wnkey="level%1:07:00::" annotator="veweser" text="The levels of ERK 1/2 were not altered by this treatment (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="18347" end="18352" sStart="null" offset="24" sid="r9.level.n.0231" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="For example, the plasma level of 7-OH-cholesterol increases from 15 ?M to approximately 200 ?M in rabbits fed with high cholesterol diet for 6 weeks [ 43 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="21413" end="21419" sStart="null" offset="103" sid="r9.level.n.0856" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="It was reported that rabbits fed with high-cholesterol diet exhibited high JNK protein levels and JNK activity in their atherosclerotic lesions, and oxidized LDL caused JNK activation in cultured smooth muscle cells [ 18 ] . Based on this study, there is a possibility that cholesterol oxides in oxidized LDL were responsible for those previous observations." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="11998" end="12004" sStart="null" offset="4" sid="r9.level.n.0556" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="The levels of ERK1/2 were similar during the first 6 hours, then dropped between 12-24 hours after treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="11334" end="11340" sStart="null" offset="48" sid="r9.level.n.0244" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="The time-dependent change in c-jun, ERK and p38 levels was determined." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-10.anc" start="25449" end="25455" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" annotator="veweser" text="The cultures were maintained in Minimum Essential Medium (MEM, GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 10% heat-inactivated fetal bovine serum (Sigma, St. Louis, MO), 1.4 mM glutamine (GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) and 20 ?M 2-mercaptoethanol (Sigma, St. Louis, MO)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-10.anc" start="25597" end="25603" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" annotator="veweser" text="The cultures were maintained in Minimum Essential Medium (MEM, GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 10% heat-inactivated fetal bovine serum (Sigma, St. Louis, MO), 1.4 mM glutamine (GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) and 20 ?M 2-mercaptoethanol (Sigma, St. Louis, MO)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-10.anc" start="25449" end="25455" sStart="null" offset="0" sid="null" wn="2147483646" wnkey="null" annotator="tofox" text="The cultures were maintained in Minimum Essential Medium (MEM, GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 10% heat-inactivated fetal bovine serum (Sigma, St. Louis, MO), 1.4 mM glutamine (GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) and 20 ?M 2-mercaptoethanol (Sigma, St. Louis, MO)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-10.anc" start="25597" end="25603" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" annotator="tofox" text="The cultures were maintained in Minimum Essential Medium (MEM, GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 10% heat-inactivated fetal bovine serum (Sigma, St. Louis, MO), 1.4 mM glutamine (GibcoBRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) and 20 ?M 2-mercaptoethanol (Sigma, St. Louis, MO)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="5743" end="5748" sStart="null" offset="139" sid="r8.1.great.j.0209" wn="1" wnkey="great%5:00:01:large:00" annotator="veweser" text="Development of PPAR agonists that retain the antiatherogenic activity but dismiss the proatherogenic activities will be of great value [ 26 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="21887" end="21893" sStart="null" offset="162" sid="r8.family.n.0663" wn="3" wnkey="family%1:14:04::" annotator="brubin" text="Activation of the JNK pathway can lead to the phosphorylation of downstream members including c-jun that belongs to the AP-1 transcription factor family [ 12 52 ] . Because results from this study indicated that JNK pathway was activated by 25-OH-cholesterol, one could expect that AP-1 would be activated in cells treated with cholesterol oxides." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-10.anc" start="591" end="597" sStart="null" offset="299" sid="r9.appear.v.0376" wn="1" wnkey="appear%2:39:00::" annotator="brubin" text="It has become clear that the pathological conditions associated with an excess level of LDL are actually caused by the oxidized products of LDL [ 1 ] . More specifically, cholesterol oxides (also termed oxysterols), the oxygenated derivatives of cholesterol, appear to be the major cytotoxic components in oxidized LDL [ 2 3 ] . These compounds have a hydroxyl- or a keto- group on the cholesterol molecule." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-10.anc" start="26477" end="26482" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" annotator="brubin" text="Cells grown in 96-well plates (20,000 cells/well, ~90% confluency) were treated with testing agents for a period of time as indicated in the figure legends; then, the viability from each treatment was determined by the MTT (3-(4,5-dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide) assay [ 66 ] . Culture medium was removed after treatment, then 100 ?l MTT solution (100 ?g/ml prepared in MEM) was &lt;b&gt;added&lt;/b&gt; to each well." />
  </sentences>
</list>